1. Home
  2. Analysis
  3. Thrive
  4. Pregabalin

Thrive and Pregabalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Thrive (nicotine polacrilex) and Pregabalin (pregabalin). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Thrive and Pregabalin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Thrive?

Thrive has active ingredients of nicotine polacrilex. eHealthMe is studying from 186 Thrive users. Check the latest studies of Thrive.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

On Jul, 28, 2026

19 people who take Thrive and Pregabalin together, and have interactions are studied.

Thrive and Pregabalin drug interactions.

What are the common drug interactions of Thrive and Pregabalin, by gender? *:

female:

  1. Drug ineffective
  2. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  3. Weight decreased
  4. Abdominal pain
  5. Anaemia (lack of blood)
  6. Colitis (inflammation of colon)
  7. Colitis ulcerative (inflammation of colon with ulcer)
  8. Constipation
  9. Erythema (redness of the skin)
  10. Female genital tract fistula (passage in genital tract of female)

male:

n/a

What are the common drug interactions of Thrive and Pregabalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Drug ineffective
  2. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  3. Weight decreased
  4. Abdominal pain
  5. Anaemia (lack of blood)
  6. Colitis (inflammation of colon)
  7. Colitis ulcerative (inflammation of colon with ulcer)
  8. Constipation
  9. Erythema (redness of the skin)
  10. Female genital tract fistula (passage in genital tract of female)

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 19 people, 100.00%
  2. Allergies: 18 people, 94.74%
  3. Nausea (feeling of having an urge to vomit): 2 people, 10.53%
  4. Urethral Disorder: 1 person, 5.26%
  5. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 5.26%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.26%
  7. Fever: 1 person, 5.26%
  8. Colitis (inflammation of colon): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Thrive and Pregabalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Thrive and Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Thrive:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thrive and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on nicotine polacrilex and pregabalin (the active ingredients of Thrive and Pregabalin, respectively), and Thrive and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.